| Literature DB >> 27277006 |
Liaqat Ali1, Abdul Latif Khan2, Javid Hussain3, Ahmed Al-Harrasi4, Muhammad Waqas5,6, Sang-Mo Kang5, Ahmed Al-Rawahi1, In-Jung Lee7.
Abstract
BACKGROUND: Medicinal plants harboring endophytic fungi could carry significant potential for producing bioactive secondary metabolites. Endophytic fungi serve as alternate source of interesting compounds in their natural and modified synthetic forms to treat different diseases. In this regard, endophytic microflora associated with alkaloid-rich medicinal plants Rhazya stricta is least known.Entities:
Keywords: Bipolaris sorokiniana LK12; Cyclic peptides; Endophytic fungi; Enzyme inhibition and antioxidant; Secondary metabolites; Structure elucidation
Mesh:
Substances:
Year: 2016 PMID: 27277006 PMCID: PMC4899901 DOI: 10.1186/s12866-016-0722-7
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Structures of the isolated compounds (1–3) from fungal endophyte Bipolaris sorokiniana LK12
Fig. 2Phylogenetic analysis of the ITS rDNA sequence of RSL-1.2 isolated from leaves of R. stricta. The analysis showed 99 % sequence homologies with Bipolaris sorokiniana. Aspergillus niger was used as an out-group
Fig. 3Key HMBC Interactions (a) and Major Mass Fragmentations (b) in Compound 1
Fig. 4Fragmentation Pattern of Protonated BZR-cotoxin I (2)
Fig. 5Fragmentation Pattern of Protonated BZR-cotoxin IV (3)
Fig. 6Enzyme Acetyl Cholinesterase inhibition activities of compound 1 – 3. The graphical lines shows standard error of means of three replications
Fig. 7Enzyme Urease inhibition activities of compound 1 – 3. The graphical lines shows standard error of means of three replications
Fig. 8Anti-Lipid Peroxidation activities of compound 1 – 3. The graphical lines shows standard error of means of three replications